Sulfite oxidase deficiency causes persulfidation loss and H2S release

Chun-Yu Fu,Joshua Benedict Kohl,Filip Liebsch,Davide D`Andrea,Max Mai,Anna Theresa Mellis,Emilia Kouroussis,Tamás Ditrói,José Angel Santamaria-Araujo,Sin Yuin Yeo,Heike Endepols,Michaela Křížkov,Viktor Kožich,Uladzimir Barayeu,Takaaki Akaike,Julia B. Hennermann,Peter Nagy,Milos Filipovic,Günter Schwarz
DOI: https://doi.org/10.1101/2024.03.13.584820
2024-03-13
Abstract:Sulfite oxidase (SOX) deficiency is a rare inborn error of cysteine metabolism resulting in severe neurological damage. In patients, sulfite accumulates to toxic levels causing a raise in downstream products -sulfocysteine (SSC), mediating excitotoxicity, and thiosulfate, a catabolic intermediate/product of H S metabolism. Here, we report a full-body knock-out mouse model for SOX deficiency (SOXD) with a severely impaired phenotype. Amongst the urinary biomarkers, thiosulfate showed a 45-fold accumulation in SOXD mice representing the major excreted S-metabolite. Consistently, we found increased plasma H S, which was derived from sulfite-induced release from persulfides as demonstrated and . Mass spectrometric analysis of total protein persulfidome identified a major loss of persulfidation in 20% of the proteome affecting enzymes in amino acids and fatty acid metabolism. Urinary amino acid profiles indicate metabolic rewiring suggesting partial reversal of the TCA cycle thus identifying a novel contribution of H S metabolism and persulfidation in SOXD.
Biology
What problem does this paper attempt to address?